Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 95.50% is 57% above its 5-year average of 60.76%, near the high end of its 5-year range (-2182.81%–100.00%).
28.14% above its 12-month average of 74.53%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
95.50%
GROSS MARGIN AVG TTM
74.53%
GROSS MARGIN AVG 3Y
100.00%
GROSS MARGIN AVG 5Y
60.76%
GROSS MARGIN AVG 10Y
23.05%
GROSS MARGIN AVG 15Y
26.38%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+28.14%
CURRENT VS 3Y AVG
-4.50%
CURRENT VS 5Y AVG
+57.18%
CURRENT VS 10Y AVG
+314.29%
CURRENT VS 15Y AVG
+261.96%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.32%
median of 679 covered companies
CURRENT VS SECTOR MEDIAN
+142.88%
vs the sector median at left
Arcturus Therapeutics Holdings Inc.
Market Cap
$379.87M
Gross Margin
95.50%
TTM Avg
74.53%
3Y Avg
100.00%
5Y Avg
60.76%
Market Cap
$383.80M
Gross Margin
69.59%
TTM Avg
67.69%
3Y Avg
68.42%
5Y Avg
70.65%
Market Cap
$372.76M
Gross Margin
25.47%
TTM Avg
27.02%
3Y Avg
15.55%
5Y Avg
5.84%
Market Cap
$390.61M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
40.00%
Market Cap
$364.94M
Gross Margin
99.87%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
83.33%
Market Cap
$399.46M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$402.21M
Gross Margin
68.83%
TTM Avg
69.91%
3Y Avg
69.67%
5Y Avg
69.68%
Market Cap
$357.99M
Gross Margin
98.15%
TTM Avg
96.49%
3Y Avg
98.25%
5Y Avg
98.83%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $379.87M | 95.50% | 74.53% | 100.00% | 60.76% |
| Orthofix Medical Inc. (OFIX)vs › | $383.80M | 69.59% | 67.69% | 68.42% | 70.65% |
| Canopy Growth Corporation (CGC)vs › | $372.76M | 25.47% | 27.02% | 15.55% | 5.84% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $390.61M | 0.00% | 0.00% | 25.00% | 40.00% |
| Opus Genetics, Inc. (IRD)vs › | $364.94M | 99.87% | 100.00% | 100.00% | 83.33% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $399.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| Myriad Genetics, Inc. (MYGN)vs › | $402.21M | 68.83% | 69.91% | 69.67% | 69.68% |
| Ocugen, Inc. (OCGN)vs › | $361.15M | 45.86% | 48.66% | 71.42% | -2398.51% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.99M | 98.15% | 96.49% | 98.25% | 98.83% |
| Carlsmed, Inc. (CARL)vs › | $402.34M | 76.63% | 74.56% | 73.66% | 73.66% |
Gross Margin
95.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | -7.87% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 80.51% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 100.00% |
| 2023-12-31 | 100.00% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 64.44% |
| 2023-03-31 | 35.52% |
| 2022-12-31 | 83.17% |
| 2022-09-30 | -181.91% |
| 2022-06-30 | -40.96% |
| 2022-03-31 | -756.08% |
| 2021-12-31 | -430.43% |
| 2021-09-30 | -1762.86% |
| 2021-06-30 | -2182.81% |
| 2021-03-31 | -2253.08% |
| 2020-12-31 | -900.27% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | -304.11% |
| 2019-09-30 | -112.57% |
| 2019-06-30 | 28.41% |
| 2019-03-31 | -68.37% |
| 2018-12-31 | 36.03% |
| 2018-09-30 | -15.95% |
| 2018-06-30 | -77.07% |
| 2018-03-31 | -66.50% |
| 2017-12-31 | 66.51% |
| 2017-09-30 | -8.10% |
| 2017-06-30 | -0.21% |
| 2017-03-31 | -4.17% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
